Origin Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,343
Closed -$281K 45
2021
Q4
$281K Hold
1,343
0.07% 31
2021
Q3
$259K Hold
1,343
0.06% 30
2021
Q2
$380K Buy
+1,343
New +$364K 0.04% 103

Other funds holding MED

Origin Asset Management's MED Position: Q1 2022 in Review

Origin Asset Management sold out of Medifast (MED) in Q1 2022, closing a stake of 1,343 shares — an estimated $281K sold.

Origin Asset Management first reported a position in MED in Q2 2021 and held it in 3 quarters. The position peaked at $380K in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Origin Asset Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Origin Asset Management sold 1,343 Medifast shares in Q1 2022, an estimated $281K.
  • Origin Asset Management first reported a position in Medifast in Q2 2021 and held it in 3 quarters.
  • Origin Asset Management's Medifast position peaked at $380K in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Origin Asset Management's 13F filing for Q1 2022, filed 24 May 2022.